The BRIC CGM market witnessed strong growth in recent decades and is further expected to grow primarily due to the increasing adaptation of continuous glucose monitoring devices in China and India. This rising diabetic population in Brazil, Russia, India, and China and increasing the adoption of CGM devices and Continuous Positive Cost-Effective Analysis by BRIC Countries will propel the growth of the BRIC CGM market. China has the largest market share in 2019; while, India is foreseen to witness a significant market share during the forecast period. According to the research analysis, the BRIC CGM market will be US$ 870 Million by the end of the year 2025.
The BRIC CGM market is driven mainly by the increasing numbers of people with diabetes across BRIC countries, growing diabetes research, and increasing international research collaborations. The Continuous Positive Cost-Effective Analysis by BRICS Countries and rapid urbanization and CGM Technology Convenient for both Patients & Physicians are further expected to contribute to the growth of this CGM market. However, Controversy regarding Clinical Benefits and the high cost of diabetes care devices are the remonstrance growth of this market.
In the year Feb 2019, Senseonics made a distribution agreement with Roche Diabetes Care for two years, giving exclusive rights to the Big Biotech for selling implantable glucose monitoring systems in Brazil, Russia, India, and China. The continuous glucose monitoring (CGM) devices market in BRIC countries are set to thrive regardless of the major upheaval caused by the COVID-19 pandemic. The surging demand for CGM in BRIC countries are primarily driven by a growing awareness of the devices and companies’ quick responses to the COVID-19 epidemic.
This latest study “BRIC CGM Market, (Brazil, Russia, India, China)Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the BRIC CGM Market.
CGM Market CGM Users CGM Reimbursements Policy Scope of the Report CGM Market & Forecast: In this report, we have fragmented the CGM market into two parts; CGM transmitter market and CGM Sensor Market. We have cover 4 countries along with growth factors. CGM Users & Forecast: We have computed CGM user of top 4 countries. Historical data is computed from 2011-2019, and forecast data would be shown from 2020-2025. Reimbursement Policy: This report provides a changing picture of Reimbursement Policy on CGM (Continuous Glucose Monitoring) BRIC and country wise. Reimbursement model of BRIC that will give the overall situation of CGM acceptance across private and public hospitals and insurer. Diabetes Population: Report covers population & forecast of 4 (Type 1 and Type 2 diabetes) Growth Factors for CGM: This report studies the key factor that would help the CGM industry to outperform. Challenges for CGM: This industry shows the problems being faced by the CGM technology and industry.
Countries Covered 1. Brazil 2. Russia 3. India 4. China
Our reports have been used by over 10K customers, including:
Artificial Pancreas Device System Market Research Report by Device Type (Control-to-Range System, Control-to-Target System, and Threshold Suspended Device System), by Treatment Type (Bi-hormonal, Hybrid, and Insulin Only), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Blood Glucose Meters - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Blood Glucose Meters - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products...
Continuous Glucose Monitoring Systems Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Continuous Glucose Monitoring Systems market including...
Blood Glucose Test Strips Market Research Report by Technology (Channel Technology and Wicking Technology), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast...
Diabetes Assays - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Diabetes Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages...
Diabetes has emerged as a global epidemic and has afflicted millions of population, worldwide. While Type-1 diabetes is caused by an immune system malfunction, Type-2 diabetes is linked to leading a sedentary lifestyle, which results in the development of inherent resistance to insulin. Hence, Type-1 diabetes can be characterized as insulin-requiring,...
Executive Summary According to the report, the Global Continuous Glucose Monitor Market is projected to display significant growth represented by a CAGR of 17.24% during 2020 - 2025. The Global Continuous Glucose Monitoring Market was valued at USD 4245.67 million in the year 2019 with North America leading the regional...
Global Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers): Opportunity Analysis and Industry Forecast, 2020–2027 The global...
Report Scope: The report will analyze the leading manufacturers of home health monitoring devices from the U.S., Europe, Asia-Pacific markets and emerging markets. The report will study these companies along various factors such as their last year’s growth, research & development and future plans and forecasts through 2025....
The global home healthcare market size is projected to reach USD 274.7 billion by 2025 from USD 181.9 billion in 2020, at a CAGR of 8.6% during the forecast period. The market growth is mainly driven by factors such as the rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.